Nasdaq Jumps 200 Points; Procter & Gamble Posts Upbeat Earnings
Portfolio Pulse from Lisa Levin
U.S. stocks traded higher with the Nasdaq Composite gaining over 200 points. Procter & Gamble reported better-than-expected Q4 results with sales growth of 5% YoY to $20.55 billion, beating the analyst consensus. Shares of Unique Fabricating, Reata Pharmaceuticals, and Bluejay Diagnostics rose significantly, while Tonix Pharmaceuticals, Sleep Number Corporation, and Mallinckrodt saw a drop in their share prices.
July 28, 2023 | 2:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Shares of Bluejay Diagnostics were up, gaining 51%.
The substantial rise in Bluejay Diagnostics' share price indicates bullish investor sentiment, which could result in further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Procter & Gamble reported better-than-expected Q4 results, beating the analyst consensus.
Procter & Gamble's better-than-expected earnings report is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Shares of Reata Pharmaceuticals got a boost, shooting 53% up.
The sharp increase in Reata Pharmaceuticals' share price suggests positive investor sentiment, which could lead to further gains in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Shares of Unique Fabricating shot up 111%.
The significant increase in Unique Fabricating's share price indicates strong investor interest, which could continue to drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Shares of Mallinckrodt fell 20%.
The significant fall in Mallinckrodt's share price suggests negative investor sentiment, which could lead to further declines in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Shares of Sleep Number Corporation were down 31%.
The substantial decrease in Sleep Number Corporation's share price indicates bearish investor sentiment, which could result in further price drops in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Shares of Tonix Pharmaceuticals dropped 39%.
The significant drop in Tonix Pharmaceuticals' share price suggests negative investor sentiment, which could lead to further declines in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100